Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.
Multidrug resistance (MDR) against chemotherapeutic agents has become the major obstacle to successful cancer therapy and multidrug resistance-associated proteins (MRPs) mediated drug efflux is the key factor for MDR. Indomethacin (IND), one of the non-steroidal anti-inflammatory agents, has been de...
Main Authors: | Weiping Ji, Bo Wang, Qiuping Fan, Chao Xu, Youwu He, Youfen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5501509?pdf=render |
Similar Items
-
Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer
by: Zhou YF, et al.
Published: (2017-08-01) -
Bioavailability Enhancement of Paclitaxel via a Novel Oral Drug Delivery System: Paclitaxel-Loaded Glycyrrhizic Acid Micelles
by: Fu-Heng Yang, et al.
Published: (2015-03-01) -
Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel
by: Zhang X, et al.
Published: (2017-12-01) -
l-Carnitine conjugated chitosan-stearic acid polymeric micelles for improving the oral bioavailability of paclitaxel
by: Tan Yang, et al.
Published: (2020-01-01) -
Synthesis and Characterization of Folate-Targeted Dextran/Retinoic Acid Micelles for Doxorubicin Delivery in Acute Leukemia
by: J. Varshosaz, et al.
Published: (2014-01-01)